Lupin shares in focus on acquisition of 3 anti-diabetes trademarks to strengthen diabetes portfolio
Global pharmaceutical giant Lupin Limited said Friday that it has strengthened its diabetes portfolio in India by acquiring the anti-diabetic trademarks GIBTULIO, GIBTULIO MET, and AJADUO from Boehringer Ingelheim International GmbH (Boehringer Ingelheim). According to the agreement, Lupin will receive the trademark rights for these brands by March of the following year. In the Indian […]